Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naim Alkhouri

Showing results (41-50 of 306) with videos related to

Pageof 31
Sort By:
Hepatobiliary Surgery and Nutrition|December 1, 2018
New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver diseaseMary Barbara, Andrea Scott, Naim Alkhouri
Hepatology Communications|July 21, 2018
Management of nonalcoholic fatty liver disease: Lessons learned from type 2 diabetesNaim Alkhouri, Fred Poordad, Eric Lawitz
Inflammatory Bowel Diseases|February 11, 2010
Pyostomatitis vegetans as an oral manifestation of Crohn's disease in a pediatric patientFouseena Pazheri, Naim Alkhouri, Kadakkal Radhakrishnan
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 25, 2012
Chronic constipation due to delayed diagnosis of a congenital anal webNeilendu Kundu, Naim Alkhouri, Federico G Seifarth
Hepatology (Baltimore, Md.)|September 26, 2020
Oligonucleotide-Based Therapeutics: An Emerging Strategy for the Treatment of Chronic Liver DiseasesNaim Alkhouri, G Kesava Reddy, Eric Lawitz
Journal of Hepatology|November 12, 2022
MEFIB vs. MAST and FAST: Not a competition but useful toolsMazen Noureddin, Stephen A Harrison, Naim Alkhouri
Journal of Pediatric Gastroenterology and Nutrition|September 3, 2010
Familial adenomatous polyposis in children and adolescentsNaim Alkhouri, James P Franciosi, Petar Mamula
Hepatology (Baltimore, Md.)|January 20, 2017
Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemicIliana Doycheva, Kymberly D Watt, Naim Alkhouri
Hepatology Communications|December 14, 2019
Designing Clinical Trials in Pediatric Nonalcoholic Steatohepatitis: Tips for Patient Selection and Appropriate EndpointsNaim Alkhouri, Rohit Kohli, Ariel E Feldstein
World Journal of Hepatology|May 31, 2024
Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challengesChencheng Xie, Naim Alkhouri, Mohamed A Elfeki
Pageof 31

Showing results (41-50 of 306) with videos related to

Sort By:
Pageof 31
Hepatobiliary Surgery and Nutrition|December 1, 2018
New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver diseaseMary Barbara, Andrea Scott, Naim Alkhouri
Hepatology Communications|July 21, 2018
Management of nonalcoholic fatty liver disease: Lessons learned from type 2 diabetesNaim Alkhouri, Fred Poordad, Eric Lawitz
Inflammatory Bowel Diseases|February 11, 2010
Pyostomatitis vegetans as an oral manifestation of Crohn's disease in a pediatric patientFouseena Pazheri, Naim Alkhouri, Kadakkal Radhakrishnan
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 25, 2012
Chronic constipation due to delayed diagnosis of a congenital anal webNeilendu Kundu, Naim Alkhouri, Federico G Seifarth
Hepatology (Baltimore, Md.)|September 26, 2020
Oligonucleotide-Based Therapeutics: An Emerging Strategy for the Treatment of Chronic Liver DiseasesNaim Alkhouri, G Kesava Reddy, Eric Lawitz
Journal of Hepatology|November 12, 2022
MEFIB vs. MAST and FAST: Not a competition but useful toolsMazen Noureddin, Stephen A Harrison, Naim Alkhouri
Journal of Pediatric Gastroenterology and Nutrition|September 3, 2010
Familial adenomatous polyposis in children and adolescentsNaim Alkhouri, James P Franciosi, Petar Mamula
Hepatology (Baltimore, Md.)|January 20, 2017
Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemicIliana Doycheva, Kymberly D Watt, Naim Alkhouri
Hepatology Communications|December 14, 2019
Designing Clinical Trials in Pediatric Nonalcoholic Steatohepatitis: Tips for Patient Selection and Appropriate EndpointsNaim Alkhouri, Rohit Kohli, Ariel E Feldstein
World Journal of Hepatology|May 31, 2024
Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challengesChencheng Xie, Naim Alkhouri, Mohamed A Elfeki
Pageof 31